These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Failure of downregulation of survivin following neoadjuvant radiochemotherapy in rectal cancer is associated with distant metastases and shortened survival. Sprenger T, Rödel F, Beissbarth T, Conradi LC, Rothe H, Homayounfar K, Wolff HA, Ghadimi BM, Yildirim M, Becker H, Rödel C, Liersch T. Clin Cancer Res; 2011 Mar 15; 17(6):1623-31. PubMed ID: 21118954 [Abstract] [Full Text] [Related]
13. High mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy. Papagrigoriadis S. Br J Cancer; 2006 Oct 09; 95(7):950; author reply 951-2. PubMed ID: 17016488 [No Abstract] [Full Text] [Related]
17. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery]. Scutari F, Tramutola G, Morlino A, Rossi MT, Manzione L, Rosati G, Sopranzi A. G Chir; 2008 Oct 09; 29(6-7):277-80. PubMed ID: 18544264 [Abstract] [Full Text] [Related]
18. Reply to M. Mohiuddin et al. Dewdney A, Hawkes EA, Cunningham D. J Clin Oncol; 2011 Jul 01; 29(19):2737-8. PubMed ID: 21850737 [No Abstract] [Full Text] [Related]
20. Adjuvant chemotherapy following neoadjuvant therapy of rectal cancer: the type of neoadjuvant therapy (chemoradiotherapy or radiotherapy) may be important for selection of patients. Fietkau R, Klautke G. J Clin Oncol; 2008 Jan 20; 26(3):507-8; author reply 508-9. PubMed ID: 18202428 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]